Kuikui Jiang

6PUBLICATIONS
12CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersTumour immunologyCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|May 26, 2026
Real-World Efficacy of Metronomic Chemotherapy in Advanced Breast Cancer Across Molecular Subtypes.

|May 19, 2026
Dynamic inflammatory biomarkers as prognostic indicators in advanced breast cancer patients receiving PD-1 inhibitors.

|Apr 17, 2024
Does the Dose of Standard Adjuvant Chemotherapy Affect the Triple-negative Breast Cancer Benefit from Extended Capecitabine Metronomic Therapy? An Exploratory Analysis of the SYSUCC-001 Trial.

Ying Chen, Wen-Xia Li, Jia-Hua Wu

|Dec 28, 2023
Construction of immune score and its prognostic value in invasive lobular carcinoma of the breast using computational pathology analysis.

Liye Wang, Peng Sun, Fei Xu

|Feb 25, 2023
Current Situation of Diagnosis and Treatment of HER2-Positive Metastatic Breast Cancer Patients in China: A Nationwide Cross-Sectional Survey of Doctors.

Kuikui Jiang, Danyang Zhou, Ruoxi Hong

|Aug 19, 2021
Establishment of Prognostic Nomograms for Predicting the Survival of HR-Positive, HER2-Negative Metastatic Breast Cancer Patients Treated with Everolimus.

Fangfang Duan, Chenge Song, Yuyu Ma

Pageof 1

Frequent Collaborators

3 joint publications

Fei Xu

3 joint publications

Shusen Wang

1 joint publications

Ji-Bin Li

1 joint publications

Cong Xue